In my last post, I wrote about the change made in January by the Food & Drug Administration (FDA) to its rules regarding the dispensing of Mifepristone, the chemical abortion drug, and the intentions of Walgreens and CVS to distribute it. I am writing today with an update of that article. 21 States said “No!”…
I began transforming into a Catholic investor while working as a portfolio manager for Northwestern Mutual Life. I had been a pro-life Catholic for a long time and was serving on the Wisconsin Right to Life Board of Directors. A stockbroker I worked with regularly approached me with a new idea for a stock to…
On December 15, 2021, the Federal Open Market Committee (FOMC) of the Federal Reserve System made a significant shift in monetary policy in response to rising inflation. The Committee accelerated the reduction of its bond-buying program in order to tighten the money supply and projected three increases in the benchmark federal funds rate in 2022,…
Much has been written about the morality of investing in the stock market, often expressed in terms of an obligation to avoid stock in companies that are engaged in immoral businesses. This can be very difficult considering the wide variety of business activities of major corporations and the diverse stock holdings in modern mutual funds,…
